Related Experiment Video

Updated: Sep 30, 2026

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor

R C Wu1, X Li, A H Schönthal

  • 1Department of Molecular Microbiology and Immunology, School of Medicine, University of Southern California, Los Angeles, USA.

Molecular and Cellular Biochemistry
|March 21, 2000
PubMed

Insights

The tumor suppressor gene PTEN inhibits cancer growth by increasing cell cycle inhibitors like p21WAF1 and enhancing apoptosis. This dual action provides a novel therapeutic strategy for advanced tumors.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Cycle Regulation

Background:

  • The PTEN gene is a known tumor suppressor frequently mutated in advanced cancers.
  • PTEN's role in suppressing tumor growth is established, but its precise mechanisms require further elucidation.

Purpose of the Study:

  • To investigate how PTEN influences cell cycle regulation to inhibit tumor cell growth.
  • To identify specific molecular pathways modulated by PTEN.

Main Methods:

  • Overexpression of PTEN in tumor cells lacking wild-type PTEN.
  • Analysis of cell cycle regulatory proteins, including cyclin-dependent kinase inhibitors (CKIs).
  • Assessment of apoptosis sensitivity and promoter activity of p21WAF1.

Main Results:

  • PTEN overexpression specifically increased the synthesis of CKIs: p21WAF1, p27KIP1, and p57KIP2.
  • PTEN induced p21WAF1 expression via p53-independent transcriptional activation.
  • Enhanced PTEN levels sensitized cells to apoptotic cell death.

Conclusions:

  • PTEN inhibits tumor growth through a two-fold mechanism.
  • Increased CKI expression and augmented apoptotic sensitivity are key effects of PTEN.

More Related Videos

Live-imaging of Breast Epithelial Cell Migration After the Transient Depletion of TIP6008:13

Live-imaging of Breast Epithelial Cell Migration After the Transient Depletion of TIP60

Published on: December 7, 2017

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...